CHRISTINA QUIN: Open Payments
NPI 1003693193 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 17 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $76 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $227 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ViiV Healthcare Company | 1 | $123 |
| Dexcom, Inc. | 1 | $115 |
| Daiichi Sankyo Inc. | 1 | $108 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $98 |
| Sumitomo Pharma America, Inc. | 1 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $73 |
| Novo Nordisk Inc | 2 | $31 |
| Iovance Biotherapeutics, Inc. | 1 | $28 |
Products named: Auvelity, REPATHA, CABENUVA, DEXCOM G7 GSS (161), INJECTAFER, KRYSTEXXA, MYFEMBREE, Wegovy.
Industry payments across MD — which companies pay providers there.
